Abbott Laboratories (ABT) Revenue & Revenue Breakdown
Abbott Laboratories Revenue Highlights
Latest Revenue (Y)
$40.11B
Latest Revenue (Q)
$10.63B
Main Segment (Y)
Medical Devices
Main Geography (Y)
UNITED STATES
Abbott Laboratories Revenue by Period
Abbott Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $40.11B | -8.12% |
| 2022-12-31 | $43.65B | 1.34% |
| 2021-12-31 | $43.08B | 24.47% |
| 2020-12-31 | $34.61B | 8.48% |
| 2019-12-31 | $31.90B | 4.34% |
| 2018-12-31 | $30.58B | 11.64% |
| 2017-12-31 | $27.39B | 31.35% |
| 2016-12-31 | $20.85B | 2.20% |
| 2015-12-31 | $20.41B | 0.78% |
| 2014-12-31 | $20.25B | -7.33% |
| 2013-12-31 | $21.85B | -45.21% |
| 2012-12-31 | $39.87B | 2.63% |
| 2011-12-31 | $38.85B | 10.48% |
| 2010-12-31 | $35.17B | 14.31% |
| 2009-12-31 | $30.77B | 4.19% |
| 2008-12-31 | $29.53B | 13.94% |
| 2007-12-31 | $25.91B | 15.30% |
| 2006-12-31 | $22.48B | 0.62% |
| 2005-12-31 | $22.34B | 13.51% |
| 2004-12-31 | $19.68B | -0.00% |
| 2003-12-31 | $19.68B | 11.29% |
| 2002-12-31 | $17.68B | 8.59% |
| 2001-12-31 | $16.29B | 18.47% |
| 2000-12-31 | $13.75B | 4.31% |
| 1999-12-31 | $13.18B | 5.61% |
| 1998-12-31 | $12.48B | 5.00% |
| 1997-12-31 | $11.88B | 7.90% |
| 1996-12-31 | $11.01B | 10.00% |
| 1995-12-31 | $10.01B | 9.35% |
| 1994-12-31 | $9.16B | 8.90% |
| 1993-12-31 | $8.41B | - |
Abbott Laboratories generated $40.11B in revenue during NA 2023, up -8.12% compared to the previous quarter, and up 131.17% compared to the same period a year ago.
Abbott Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $10.63B | 2.49% |
| 2024-06-30 | $10.38B | 4.14% |
| 2024-03-31 | $9.96B | -2.70% |
| 2023-12-31 | $10.24B | 0.97% |
| 2023-09-30 | $10.14B | 1.65% |
| 2023-06-30 | $9.98B | 2.37% |
| 2023-03-31 | $9.75B | -3.41% |
| 2022-12-31 | $10.09B | -3.06% |
| 2022-09-30 | $10.41B | -7.52% |
| 2022-06-30 | $11.26B | -5.36% |
| 2022-03-31 | $11.89B | 3.72% |
| 2021-12-31 | $11.47B | 4.94% |
| 2021-09-30 | $10.93B | 6.90% |
| 2021-06-30 | $10.22B | -2.23% |
| 2021-03-31 | $10.46B | -2.29% |
| 2020-12-31 | $10.70B | 20.87% |
| 2020-09-30 | $8.85B | 20.81% |
| 2020-06-30 | $7.33B | -5.15% |
| 2020-03-31 | $7.73B | -7.07% |
| 2019-12-31 | $8.31B | 2.95% |
| 2019-09-30 | $8.08B | 1.22% |
| 2019-06-30 | $7.98B | 5.89% |
| 2019-03-31 | $7.54B | -2.96% |
| 2018-12-31 | $7.76B | 1.42% |
| 2018-09-30 | $7.66B | -1.43% |
| 2018-06-30 | $7.77B | 5.10% |
| 2018-03-31 | $7.39B | -2.62% |
| 2017-12-31 | $7.59B | 11.13% |
| 2017-09-30 | $6.83B | 2.89% |
| 2017-06-30 | $6.64B | 4.77% |
| 2017-03-31 | $6.33B | 18.79% |
| 2016-12-31 | $5.33B | 0.58% |
| 2016-09-30 | $5.30B | -0.58% |
| 2016-06-30 | $5.33B | 9.17% |
| 2016-03-31 | $4.88B | -5.84% |
| 2015-12-31 | $5.19B | 0.74% |
| 2015-09-30 | $5.15B | -0.39% |
| 2015-06-30 | $5.17B | 5.57% |
| 2015-03-31 | $4.90B | -7.43% |
| 2014-12-31 | $5.29B | 3.64% |
| 2014-09-30 | $5.10B | -8.05% |
| 2014-06-30 | $5.55B | 5.85% |
| 2014-03-31 | $5.24B | -7.27% |
| 2013-12-31 | $5.65B | 5.32% |
| 2013-09-30 | $5.37B | -1.41% |
| 2013-06-30 | $5.45B | 1.27% |
| 2013-03-31 | $5.38B | -50.37% |
| 2012-12-31 | $10.84B | 10.88% |
| 2012-09-30 | $9.77B | -0.35% |
| 2012-06-30 | $9.81B | 3.71% |
| 2012-03-31 | $9.46B | -8.87% |
| 2011-12-31 | $10.38B | 5.71% |
| 2011-09-30 | $9.82B | 2.08% |
| 2011-06-30 | $9.62B | 6.36% |
| 2011-03-31 | $9.04B | -9.30% |
| 2010-12-31 | $9.97B | 14.91% |
| 2010-09-30 | $8.67B | -1.72% |
| 2010-06-30 | $8.83B | 14.65% |
| 2010-03-31 | $7.70B | -12.42% |
| 2009-12-31 | $8.79B | 13.26% |
| 2009-09-30 | $7.76B | 3.56% |
| 2009-06-30 | $7.49B | 11.56% |
| 2009-03-31 | $6.72B | -15.50% |
| 2008-12-31 | $7.95B | 6.04% |
| 2008-09-30 | $7.50B | 2.51% |
| 2008-06-30 | $7.31B | 8.11% |
| 2008-03-31 | $6.77B | -6.31% |
| 2007-12-31 | $7.22B | - |
Abbott Laboratories generated $10.63B in revenue during Q3 2024, up 2.49% compared to the previous quarter, and up 106.58% compared to the same period a year ago.
Abbott Laboratories Revenue Breakdown
Abbott Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Nutritional Products | $8.15B | $7.46B | $8.29B | $7.65B | $7.41B |
| Established Pharmaceutical Products | $5.07B | $4.91B | $4.72B | $4.30B | $4.49B |
| Medical Devices | $16.89B | $14.69B | $435.00M | $430.00M | $380.00M |
| Diagnostic Products | $9.99B | $16.58B | $4.00B | $3.80B | $3.30B |
Abbott Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Medical Devices (42.12%), Diagnostic Products (24.91%), Nutritional Products (20.34%), and Established Pharmaceutical Products (12.63%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices | $4.75B | $4.73B | $4.45B | $4.44B | $4.25B | $475.00M | $450.00M | $433.00M | $436.00M | $428.00M | $3.75B | $445.00M | $414.00M | $400.00M | $3.26B | $430.00M | $415.00M | $400.00M | - | - |
| Diagnostic Products | $5.30B | $4.80B | $4.50B | - | $4.20B | $4.20B | $4.10B | $3.90B | $3.90B | $3.80B | $4.47B | $3.90B | $3.90B | $3.80B | $4.34B | $3.60B | $3.50B | $3.40B | $2.06B | $3.20B |
| Established Pharmaceutical Products | $1.41B | $1.29B | $1.23B | $1.22B | $1.37B | $1.15B | $1.20B | $1.26B | $1.18B | $1.07B | $1.15B | $1.10B | $1.01B | $1.04B | $1.17B | $1.21B | - | - | - | - |
| Nutritional Products | $2.07B | $2.15B | $2.07B | $2.04B | $2.07B | $1.89B | $2.04B | $2.11B | $2.11B | $2.04B | $1.94B | $1.92B | $1.88B | $1.90B | $1.87B | $1.87B | - | - | - | - |
| Other Segment | - | - | - | - | - | - | - | - | - | $3.00M | $3.00M | $11.00M | - | - | - | - | - | - | - | - |
| All Other Segments | - | - | - | - | - | - | - | - | - | - | - | - | $22.00M | $16.00M | $16.00M | $20.00M | $15.00M | $15.00M | $681.00M | - |
| Cardiovascular And Neuromodulation Products | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $350.00M |
Abbott Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Diagnostic Products (39.20%), Medical Devices (35.11%), Nutritional Products (15.28%), and Established Pharmaceutical Products (10.40%).
Abbott Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| NETHERLANDS | $1.07B | - | - | - | - |
| JAPAN | $1.51B | $1.93B | - | - | - |
| INDIA | $1.75B | $1.65B | - | - | - |
| GERMANY | $2.35B | $2.34B | - | - | - |
| SWITZERLAND | $1.64B | $1.34B | - | - | - |
| CHINA | $2.25B | $2.13B | - | - | - |
| Non-US | $14.08B | $14.84B | - | - | - |
| UNITED STATES | $15.45B | $18.14B | - | - | - |
| CANADA | - | $1.28B | - | - | - |
| All Other Countries | - | $14.84B | $15.52B | - | - |
| Canada | - | - | $1.39B | - | - |
| China | - | - | $2.39B | - | - |
| Germany | - | - | $2.57B | - | - |
| India | - | - | $1.56B | - | - |
| Japan | - | - | $1.70B | - | - |
| Switzerland | - | - | $1.31B | - | - |
| I | - | - | - | $1.32B | $1.40B |
| J | - | - | - | $1.39B | $1.44B |
| N | - | - | - | $1.08B | $975.00M |
| Other Countries | - | - | - | $12.58B | $11.53B |
| D | - | - | - | $2.11B | $1.75B |
| C | - | - | - | $1.14B | $1.07B |
Abbott Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (38.53%), Non-US (35.11%), GERMANY (5.85%), CHINA (5.62%), INDIA (4.36%), SWITZERLAND (4.08%), JAPAN (3.77%), and NETHERLANDS (2.68%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $6.43B | $6.44B | $6.12B | - | $6.33B | $6.22B | $5.82B | $5.87B | $6.32B | $6.37B | - |
| UNITED STATES | $4.20B | $3.93B | $3.85B | $3.95B | $3.82B | $3.76B | $3.93B | $4.22B | $4.09B | $4.89B | - |
| U | - | - | - | - | - | - | - | - | - | - | $94.00M |
| Non Us | - | - | - | - | - | - | - | - | - | - | $336.00M |
Abbott Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: Non-US (60.49%), and UNITED STATES (39.51%).
ABT Revenue FAQ
What is Abbott Laboratories’s yearly revenue?
Abbott Laboratories's yearly revenue for 2023 was $40.11B, representing a decrease of -8.12% compared to 2022. The company's yearly revenue for 2022 was $43.65B, representing an increase of 1.34% compared to 2021. ABT's yearly revenue for 2021 was $43.08B, representing an increase of 24.47% compared to 2020.
What is Abbott Laboratories’s quarterly revenue?
Abbott Laboratories's quarterly revenue for Q3 2024 was $10.64B, a 2.49% increase from the previous quarter (Q2 2024), and a 4.85% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $10.38B, a 4.14% increase from the previous quarter (Q1 2024), and a 4.00% increase year-over-year (Q2 2023). ABT's quarterly revenue for Q1 2024 was $9.96B, a -2.70% decrease from the previous quarter (Q4 2023), and a 2.23% increase year-over-year (Q1 2023).
What is Abbott Laboratories’s revenue growth rate?
Abbott Laboratories's revenue growth rate for the last 3 years (2021-2023) was -6.89%, and for the last 5 years (2019-2023) was 25.72%.
What are Abbott Laboratories’s revenue streams?
Abbott Laboratories's revenue streams in c 23 are Nutritional Products, Established Pharmaceutical Products, Medical Devices, and Diagnostic Products. Nutritional Products generated $8.15B in revenue, accounting 20.34% of the company's total revenue, up 9.32% year-over-year. Established Pharmaceutical Products generated $5.07B in revenue, accounting 12.63% of the company's total revenue, up 3.14% year-over-year. Medical Devices generated $16.89B in revenue, accounting 42.12% of the company's total revenue, up 14.98% year-over-year. Diagnostic Products generated $9.99B in revenue, accounting 24.91% of the company's total revenue, down -39.77% year-over-year.
What is Abbott Laboratories’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Abbott Laboratories was Medical Devices. This segment made a revenue of $16.89B, representing 42.12% of the company's total revenue.